Uterine leiomyomas (fibroids) occur in 20–25% of women of childbearing age and are symptomatic in 10-20%. African-American women are at higher risk, and as many as 50% have fibroids. Symptomatic fibroids are the leading cause of hysterectomy in the United States, accounting for 1/3 of the over 600,000 hysterectomies performed in this country each year.
Uterine fibroid embolization (UFE), also known as uterineartery embolization (UAE), is a safe and effective minimally invasive treatment for the management of symptomatic uterine fibroids.
This procedure, performed by interventional radiologists, is a valuable treatment option to hysterectomy or myomectomy for many women suffering with fibroids. The most common presenting symptoms are heavy bleeding, pelvic pain and/or pressure, and increased urinary frequency.
Patients are often discharged the day of the procedure, with the remainder discharged within 24 hours. This has allowed UFE to be performed in the outpatient setting. The majority of patients are able to return to normal activities in 7–10 days.
Interventional Radiology at Lawrence
Marc Hamet, MD, leads a team of Board-certified Interventional Radiologists who perform uterine fibroid embolizations at Lawrence. He is a graduate of the University of Maryland Medical School and was the Chief Fellow in Cardiovascular/Interventional Radiology at Johns Hopkins Hospital. He is Board certified with the American Board of Radiology with Certificates of Added Qualification in Neuroradiology and Interventional Radiology.